Recruitment Account Manager, UK

commercialcareers@inventivhealth.com

We are here to support you!

I am Rebekah Choulses, Jr. Recruitment Account Manager at Syneos Health.

I am supporting our recruitment efforts for this exciting project together with my UK peers.

It will be my pleasure to support you in the achievement of your career objectives.

Transparency and openness are basic values of Syneos Health. We want you to know as much as possible right from the start as we believe in a simple truth: The more you know, the more you are excited and the more we share, the more comfortable and welcomed do you feel.

 

Please note that the following is no medical advice but a short summary of the most important basic facts about two chronic diseases which affect in total more than six million people in the United Kingdom. If you think you might suffer from COPD or Asthma, please consult your doctor!

England (t).png
Wales (t).png
Company.png
COPD.png
 

What is Asthma?

 

The website of the "Asthma UK" (www.asthma.org.uk) describes it as follows: "Asthma is a long-term condition that affects your airways - the tubes that carry air in and out of your lungs.

You could say that someone with asthma has 'sensitive' airways that are inflamed and ready to react when they come into contact with something they don't like."

Further to this, Asthma UK - an organisation which has its roots in the 1920s - writes: "

When a person with asthma comes into contact with one of their asthma triggers it causes their airways to react in three ways:

  1. The muscles around the walls of the airways tighten so that the airways become narrower.

  2. The lining of the airways becomes inflamed and starts to swell.

  3. Sticky mucus or phlegm sometimes builds up, which can narrow the airways even more.

​​​These reactions in the airways make it difficult to breathe and lead to asthma symptoms, such as chest tightness, wheezing, or coughing."

Recruitment Account Manager, UK

commercialcareers@inventivhealth.com

How is it treated?

 

Asthma is a chronic disease. It has no cure which would make it disappear. Concerning the US American Heart, Lung, and Blood Institute (NIH) there are two types of medicines for its treatment: "...long-term control and quick-relief medicines. Long-term control medicines help reduce airway inflammation and prevent asthma symptoms. Quick-relief, or "rescue," medicines relieve asthma symptoms that may flare up."

 

For long-term medicines, there are different options available. The NIH lists:

 

  • Inhaled corticosteroids which are seen as the most effective option for long-term relief of the inflammation and swelling that makes the airways sensitive to certain inhaled substances.

  • Anti-inflammatory medicine, which is taken using a device called a "nebulizer." As the patient breathes in, the nebulizer sends a fine mist of medicine to the lungs. It is used to prevent airway inflammation.

  • Immunomodulators (anti-IgE), a shot (injection) one or two times a month. It helps prevent the body from reacting to asthma triggers, such as pollen and dust mites. Anti-IgE might be used if other asthma medicines have not worked well. 

  • Inhaled long-acting beta2-agonists to open the airways. They might be added to inhaled corticosteroids to improve asthma control. 

  • Leukotriene modifiers which are taken orally. They help block the chain reaction that increases inflammation in the airways.

  • Theophylline, an oral medicine which helps to open the airways.

 

 

Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to address new market realities where clinical and commercial share expertise, data and insights to accelerate biopharmaceutical performance.

European Headquarters

 

10 Bloomsbury Way

WC1A

London

United Kingdom

 

Phone: +44 (0) 20 7632 1800